Denis Chem Lab Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 537536
₹67.81
Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #142 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Sun Pharmaceutical Industries Limited 435,863 146.5 13.7% 11.0% — 72 8 30
Divi's Laboratories Limited 246,660 83.9 15.3% 62.7% 0.32% 70 4 51
Torrent Pharmaceuticals Limited 162,454 78.2 12.2% 34.6% 0.79% 56 0 31
Zydus Lifesciences Limited 115,910 33.3 17.3% 17.2% 0.09% 74 24 84
Cipla Limited 108,736 35.4 11.2% -11.0% 0.97% 73 29 62
Laurus Labs Limited 106,969 122.5 17.1% 127.1% — 78 24 53
Mankind Pharma Limited 103,406 47.4 11.7% 2.6% — 68 12 86
Dr. Reddy's Laboratories Limited 102,916 154.7 10.9% -0.9% — 62 33 71
Denis Chem Lab Limited (this stock) 94 11.8 8.7% -61.7% — 64 96 43

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹98 Cr
EV / EBITDA
5.2x
EV / Sales
0.54x
Market cap / Sales
0.52x
Earnings yield
8.48%

Quarterly Financials

↑ Positive
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 44 Cr, up 2.0% YoY.

↓ Negative
Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 2 Cr, down 17.4% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 44 3 2 ₹1.4700
March 31, 2026 47 1 0 ₹0.2900
Dec. 31, 2025 46 4 3 ₹2.3900
Sept. 30, 2025 46 3 — ₹1.6000
June 30, 2025 43 3 2 ₹1.7800
March 31, 2025 41 1 — ₹0.5100
Dec. 31, 2024 43 2 2 ₹1.2700
Sept. 30, 2024 48 5 4 ₹2.5400
June 30, 2024 41 3 2 ₹1.5000
March 31, 2024 40 4 3 ₹1.9700
Dec. 31, 2023 40 4 3 ₹2.3100
Sept. 30, 2023 45 4 3 ₹1.8300
June 30, 2023 42 3 3 ₹1.9300

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Total income (before exceptional items)44474647444343484240404642
Operating revenue44474646434143484140404542
Other income0101010101010
Operating expenses40443942383939423735344037
Operating profit4364524645655
Operating profit margin8.7%5.4%13.2%9.2%11.1%5.0%8.9%12.3%10.5%12.7%14.9%11.3%11.8%
Depreciation2222222222222
Interest0000000000000
Exceptional items, gain / (loss)—————————————
Profit before tax3143312534443
Tax1111110111111
Net profit203—2—2423333
EPS1.470.292.391.601.780.511.272.541.501.972.311.831.93
Net profit (TTM)——————10121111988
EPS (TTM)5.756.066.285.166.105.827.288.327.618.046.635.646.05

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 20Mar 18Mar 17
Total income (before exceptional items) 4.4% 10.9% 184†176†169†161†138†110†137†109†114†
Operating revenue 4.2% 10.7% 182†173†168†161†137†109†136†108†113†
Other income — — 2†2†1†1†1†0†0†1†1†
Operating expenses — — 164†157†147†142†122†99†121†96†95†
Operating profit -2.0% 11.5% 18†16†21†19†14†10†15†12†18†
Operating profit margin — — 9.7%†9.3%†12.7%†11.7%†10.5%†9.4%†10.9%†11.1%†16.2%†
Depreciation — — 7†7†7†8†6†6†7†6†7†
Interest — — 1†1†1†1†1†2†3†5†6†
Exceptional items, gain / (loss) — — 0†0†0†0†0†0†0†0†0†
Profit before tax 2.9% 31.0% 12†11†15†11†9†3†6†2†2†
Tax — — 3†3†4†3†3†1†2†——
Net profit — — ——11†8†6†2†4†2†1†
EPS 2.2% 30.0% 6.06†5.82†8.04†5.67†4.52†1.63†3.03†——

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 20Mar 18Mar 17
Operating margin9.7%†9.3%†12.7%†11.7%†10.5%†9.4%†10.9%†11.1%†16.2%†
EBIT margin7.0%†6.7%†9.3%†7.2%†7.1%†4.2%†6.3%†6.1%†6.9%†
PBT margin6.5%†6.4%†9.0%†6.8%†6.5%†2.8%†4.2%†1.9%†1.8%†
Net margin——6.6%†4.9%†4.6%†2.1%†3.1%†2.0%†1.1%†
Interest coverage15.15x†22.77x†28.86x†18.02x†12.75x†2.99x†2.98x†1.44x†1.34x†
Dividend payout—————————
Earnings retention—————————
Current ratio2.70x2.71x———————
Quick ratio2.36x2.33x———————
Debt to equity0.05x0.01x———————
Return on equity—————————
Return on assets—————————
Return on capital employed13.7%†13.5%†———————
Asset turnover1.46x†1.54x†———————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 4 -5 0 5 -1
March 31, 2025 12 -8 -4 8 4

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 125 92 78 4 0 85 32 0 37 11
March 31, 2025 112 85 71 0 0 71 26 1 39 10

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.